Quantum Biopharma QNTM Cash Flow Statement (2019-2026)

NASDAQ QNTM
$3.58 +0.29 (+8.81%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Quantum Biopharma Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Quantum Biopharma reported cash from operations of -$0.00B and free cash flow of -$0.00B for the quarter ended Jun 2026, up 8.2% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.01B0.00B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-1544.77B-0.02B-0.00B0.01B-0.02B0.03B0.01B0.01B-0.05B0.05B0.01B0.00B
Share-based CompensationStock Comp.
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Cash from Discontinued OperationsCash from Discont. Ops
0.00B-0.00B-0.00B
Gains from Equity InvestmentsGains Equity
0.00B0.00B0.00B
Gains from Sales and DivestituresGains Divest
-0.00B
Gains from Investment SecuritiesGains Investment
-0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B-0.00B0.01B0.00B
Asset Writedowns and ImpairmentWritedown
-0.00B0.00B0.00B0.00B
Cash from OperationsCash from Ops.
0.00B-0.04B0.01B0.01B0.01B-0.05B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Depreciation & Amortization (CF)Dep. & Amort.
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in ReceivablesChange Receivables
-0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B
Change in InventoryChange Inventory
-0.00B0.00B0.00B0.00B665.00-0.00B
Change in Account PayablesChange Payables
-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B
Investing Activities
Capital ExpendituresCapex
0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B222.00-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00B0.00B0.00B0.00B
Acquisitions
Divestments
Change in Acquisitions & DivestmentsChange Acquisitions
0.00B-0.00B-0.00B0.00B-0.00B0.01B-0.01B0.00B-0.00B0.00B0.00B
Cash from Investing ActivitiesCash from Investing
0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B
Financing Activities
Other financing activitiesOther financing
0.00B0.00B0.00B-0.00B0.00B0.00B
Cash from Financing ActivitiesCash from Financing
-0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.01B0.00B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Net Equity Issued and RepurchasedNet Equity Issued
34.000.00B0.00B0.01B0.00B0.01B0.00B
Additional items
Exchange Rate EffectFX Effect
-0.00B0.03B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B-0.00B
Change in Cash
-0.00B-0.00B0.01B-0.00B0.01B-0.03B-0.01B-0.01B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B
Beginning Cash Balance
0.02B0.02B0.04B0.04B0.04B0.04B0.02B0.02B0.02B0.02B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.00B0.00B
Free Cash FlowFCF
0.00B-0.04B0.01B0.01B0.01B-0.05B-0.00B-0.01B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B
Net Cash FlowNCF
0.01B-0.04B0.01B0.01B0.01B-0.05B-0.01B-0.00B-0.01B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B